26 results on '"Meredith, P.A."'
Search Results
2. Nifedipine GITS
3. Improving blood pressure control in patients with diabetes mellitus and high cardiovascular risk
4. Benefits of nifedipine GITS in stable coronary artery disease: further analysis of the “ACTION” database
5. Steady state PK of doxazosin GITS versus doxazosin standard and the potential benefits of GITS in the treatment of hypertensive patients
6. Outcome differences between ACE inhibitor and calcium channel blocker treated hypertensives
7. ACE inhibitors and outcome in treated hypertensive patients
8. G-015 PROGNOSTIC VALUE OF BLOOD PRESSURE AND “EARLY” BLOOD PRESSURE CONTROL IN PATIENTS WITH CORONARY ARTERY DISEASE.
9. G-006 CARDIOVASCULAR OUTCOMES IN HYPERTENSIVES TREATED EXCLUSIVELY WITH NIFEDIPINE GITS OR CO-AMILOZIDE.
10. G-003 BENEFITS OF NIFEDIPINE GITS IN STABLE CORONARY ARTERY DISEASE.
11. A031: ACE inhibitors and outcome in treated hypertensive patients.
12. A032: Outcome differences between ACE inhibitor and calcium channel blocker treated hypertensives.
13. A062: Steady state PK of doxazosin GITS versus doxazosin standard and the potential benefits of GITS in the treatment of hypertensive patients.
14. An assessment of the pharmacokinetics and pharmacodynamics of single doses of amlodipine in elderly normotensives
15. The influence of age on the pharmacokinetics of verapamil
16. Assessment of the PKU card as a retrospective index of neonatal blood lead status
17. Delta-aminolaevulinic acid metabolism in normal and lead-exposed humans
18. Antihypertensive drugs: Individualized analysis and clinical relevance of kinetic-dynamic relationships
19. The determination of trimazosin and its metabolite CP23445 in whole blood by high performance liquid chromatography using fluorescence detection
20. The determination of labetalol in plasma by high-performance liquid chromatography using fluorescence detection
21. The percutaneous absorption of lead-203 in humans from cosmetic preparations containing lead acetate, as assessed by whole-body counting and other techniques
22. DO ace inhibitors protect against cancer?
23. Cancer risk in hypertensive patients treated with calcium channel blockers.
24. Do ace inhibitors reduce mortality in hypertensive patients?
25. Efficacy of low-density-lipoprotein lowering with statins
26. The physiologically realistic characterisation of benazeprilat pharmacokinetics in young and elderly volunteers
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.